Nuclear matrix protein (NMP) 22, a regulator of mitosis, is known to be increased in malignant urothelium, and quantitative immunoassay of NMP22 demonstrates superior sensitivity for bladder cancer compared to urine cytology [25]. The gene discussed is NUMA1; the disease is urinary bladder carcinoma.